5/17/22 17:12 | 5/13/22 | CMPI | Checkmate Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Venbio Global Strategic Fund II L.P. | CA | T | | S.m | -1,376 | 10.45 | 0 | -132 | -6 | 2,156 | D | | | | | | | | | | | | | | |
5/12/22 20:47 | 5/10/22 | CMPI | Checkmate Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Venbio Global Strategic Fund II L.P. | CA | T | | S.m | -1,672 | 10.39 | 0 | -161 | -7 | 2,288 | D | | | | | | | | | | | | | | |
5/9/22 18:58 | 5/5/22 | CMPI | Checkmate Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Venbio Global Strategic Fund II L.P. | CA | T | | S.m | -899 | 10.37 | 0 | -87 | -3 | 2,448 | D | | | | | | | | | | | | | | |
5/4/22 19:30 | 5/2/22 | CMPI | Checkmate Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Venbio Global Strategic Fund II L.P. | CA | T | | S.m | -2,809 | 10.38 | 0 | -271 | -10 | 2,535 | D | | | | | | | | | | | | | | |
4/29/22 17:50 | 4/27/22 | CMPI | Checkmate Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Venbio Global Strategic Fund II L.P. | CA | T | | S.m | -1,973 | 10.38 | 0 | -190 | -6 | 2,806 | D | | | | | | | | | | | | | | |
4/26/22 18:40 | 4/22/22 | CMPI | Checkmate Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Venbio Global Strategic Fund II L.P. | CA | T | | S.m | -1,348 | 10.39 | 0 | -130 | -4 | 2,996 | D | | | | | | | | | | | | | | |
4/21/22 20:54 | 4/19/22 | CMPI | Checkmate Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Venbio Global Strategic Fund II L.P. | CA | T | | S.m | -5,700 | 10.41 | 0 | -548 | -15 | 3,126 | D | | | | | | | | | | | | | | |
4/29/21 18:44 | 4/27/21 | IMPL | Impel Neuropharma Inc | DE | Health | Drug | Pharmaceutical Preparations | Venbio Global Strategic Fund II L.P. | CA | T | | P.d | 6,750 | 15.00 | 0 | 450 | 19 | 2,760 | D | | | | | | | | | | | | | | |
8/12/20 21:00 | 8/11/20 | CMPI | Checkmate Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Venbio Global Strategic Fund II L.P. | CA | T | | P.d | 3,000 | 15.00 | 0 | 200 | 6 | 3,673 | D | | | | | | | | | | | | | | |
7/6/20 19:00 | 7/1/20 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Venbio Global Strategic Fund II L.P. | CA | T | | S.m | -4,007 | 34.40 | 0 | -116 | -4 | 3,034 | I | | | | | | | | | | | | | | |
3/6/20 17:23 | 3/4/20 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Venbio Global Strategic Fund II L.P. | CA | T | | S.m | -1,092 | 23.76 | 0 | -46 | -1 | 3,150 | I | | | | | | | | | | | | | | |
3/3/20 17:52 | 2/28/20 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Venbio Global Strategic Fund II L.P. | CA | T | | S.m | -493 | 22.63 | 0 | -22 | -1 | 3,196 | I | | | | | | | | | | | | | | |
2/27/20 19:51 | 2/25/20 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Venbio Global Strategic Fund II L.P. | CA | T | | S.m | -135 | 22.80 | 0 | -6 | 0 | 3,228 | I | | | | | | | | | | | | | | |
2/12/20 17:56 | 2/10/20 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Venbio Global Strategic Fund II L.P. | CA | T | | S.m | -271 | 27.07 | 0 | -10 | 0 | 3,234 | I | | | | | | | | | | | | | | |
2/10/20 17:47 | 2/6/20 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Venbio Global Strategic Fund II L.P. | CA | T | | S | -165 | 27.03 | 0 | -6 | 0 | 3,234 | I | | | | | | | | | | | | | | |
2/6/20 16:06 | 2/4/20 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Venbio Global Strategic Fund II L.P. | CA | T | | S.m | -2,122 | 25.77 | 0 | -82 | -2 | 3,240 | I | | | | | | | | | | | | | | |
1/14/20 08:58 | 1/13/20 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Venbio Global Strategic Fund II L.P. | CA | T | | S | -9,994 | 20.23 | 0 | -494 | -13 | 3,322 | I | | | | | | | | | | | | | | |
1/10/20 16:06 | 1/8/20 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Venbio Global Strategic Fund II L.P. | CA | T | | S | -311 | 19.86 | 0 | -16 | 0 | 3,816 | I | | | | | | | | | | | | | | |
1/8/20 16:10 | 1/6/20 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Venbio Global Strategic Fund II L.P. | CA | T | | S.m | -1,455 | 19.86 | 0 | -73 | -2 | 3,832 | I | | | | | | | | | | | | | | |
1/6/20 16:07 | 1/2/20 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Venbio Global Strategic Fund II L.P. | CA | T | | S.m | -700 | 19.71 | 0 | -35 | -1 | 3,905 | I | | | | | | | | | | | | | | |
1/3/20 16:13 | 12/31/19 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Venbio Global Strategic Fund II L.P. | CA | T | | S | -343 | 23.96 | 0 | -14 | 0 | 3,941 | I | | | | | | | | | | | | | | |
6/25/19 09:20 | 6/24/19 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Venbio Global Strategic Fund II L.P. | CA | T | | P.d | 4,000 | 16.00 | 0 | 250 | 7 | 3,955 | I | | | | | | | | | | | | | | |
1/29/18 16:22 | 1/25/18 | MNLO | Menlo Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Venbio Global Strategic Fund II L.P. | CA | T | | P.d | 4,505 | 17.00 | 0 | 265 | 22 | 1,462 | D | | | | | | | | | | | | | | |
11/13/17 16:27 | 11/13/17 | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Venbio Global Strategic Fund II L.P. | CA | T | | P.d | 1,785 | 14.00 | 0 | 128 | 4 | 3,579 | D | | | | | | | | | | | | | | |